Veronique Dehlinger

Title: Veronique Dehlinger: Innovator in Pharmaceutical Chemistry

Introduction

Veronique Dehlinger is a prominent inventor based in Weybridge, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 2 patents, her work has the potential to impact various medical conditions.

Latest Patents

One of her latest patents is for 3-indazolyl-4-pyridylisothiazoles. This invention provides 3-indazolyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions and methods of using the same. Additionally, she has developed 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists. This invention relates to compounds that are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia, and migraine.

Career Highlights

Veronique Dehlinger is currently associated with Eli Lilly and Company, where she continues to advance her research and development efforts. Her innovative work in pharmaceutical chemistry has garnered attention and respect within the scientific community.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Thomas Charles Britton and Adam Michael Fivush. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Veronique Dehlinger is a trailblazer in the field of pharmaceutical chemistry, with a focus on developing innovative compounds for treating various medical conditions. Her contributions through her patents and collaborations highlight her commitment to advancing healthcare solutions.